Jun 6, 2023
Mimicry Solutions (Mimicry), www.mimicrysolutions.com, has entered into an agreement with Cooley LLP (Cooley) for corporate advisory, general counsel and IP matters.
Cooley is known for its technology and life sciences practices as well as its experience with initial public offerings (IPOs), deep-rooted venture capital connections, and financing. Cooley is a highly revered law firm, particularly for their focus on helping and advising emerging startups.
The engagement with Cooley will ensure complete compliance and best interest for Mimicry in all business decisions including partnership agreements, fundraising and financing, and business operations. Additionally, Cooley will oversee and handle the creation and filing of Mimicry's future patents as well as all matters related to Mimicry's intellectual property.
Mimicry is excited to have Cooley on board, providing the utmost confidence and support in all future corporate endeavors.
About Mimicry Solutions
Mimicry Solutions is disrupting the pharmaceutical industry with ARTEMIS™, a proprietary toxicology platform that is the first ever alternative to animal testing for drug safety assessments at the industry level. ARTEMIS™ will generate novel toxicological readouts that outperform animals, providing better safety assessments of new drugs, faster drug development timelines, and a reduced ethical burden in animal research. Learn more at www.mimicrysolutions.com.